Structures by: Riahi A.
Total: 18
(3a<i>R</i>,6<i>R</i>)-3,3,6-Trimethyl-3,3a,4,5,6,7-hexahydro-2<i>H</i>-indazole-2-carbothioamide
C11H19N3S
IUCrData (2016) 1, 4 x160573
a=7.957(5)Å b=10.796(5)Å c=13.673(5)Å
α=90.00° β=90.00° γ=90.00°
(2<i>E</i>)-<i>N</i>-Methyl-2-[1-(4-methylcyclohex-3-en-1-yl)ethylidene]hydrazinecarbothioamide
C11H19N3S
IUCrData (2017) 2, 4 x170513
a=12.2974(4)Å b=13.7295(4)Å c=14.8952(5)Å
α=90° β=90° γ=90°
Dimethyl 4-hydroxy-2,5-dimethylisophthalate
C12H14O4
Organic & Biomolecular Chemistry (2009) 7, 10 2182-2186
a=7.4507(4)Å b=10.6081(6)Å c=14.7549(9)Å
α=77.052(4)° β=78.918(3)° γ=81.775(3)°
Dimethyl 4'-chloro-2-hydroxy-4-methylbiphenyl-3,5-dicarboxylate
C17H15ClO5
Organic & Biomolecular Chemistry (2009) 7, 10 2182-2186
a=4.0186(2)Å b=33.9422(15)Å c=11.3074(5)Å
α=90.00° β=98.435(3)° γ=90.00°
C14H14O3S
C14H14O3S
Organic & Biomolecular Chemistry (2008) 6, 19 3542-3551
a=7.0866(5)Å b=9.2066(7)Å c=10.2121(9)Å
α=95.843(4)° β=105.477(5)° γ=98.661(5)°
Methyl 4-(fur-2-yl)-6-trifluormethyl-salicylate
C13H9F3O4
Organic & Biomolecular Chemistry (2008) 6, 19 3542-3551
a=13.851(3)Å b=4.8284(10)Å c=35.183(7)Å
α=90.00° β=90.00° γ=90.00°
Methyl 4-(thien-2-yl)-6-trifluormethyl-salicylate
C13H9F3O3S
Organic & Biomolecular Chemistry (2008) 6, 19 3542-3551
a=13.840(3)Å b=4.9310(10)Å c=35.860(7)Å
α=90.00° β=90.00° γ=90.00°
(<i>Z</i>)-3-Methyl-2-{(<i>E</i>)-[(1<i>R</i>,4<i>R</i>)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-ylidene]hydrazinylidene}thiazolidin-4-one
C14H21N3OS
Acta Crystallographica Section C (2018) 74, 12
a=7.1606(4)Å b=7.2405(3)Å c=28.2842(14)Å
α=90° β=90° γ=90°
(2<i>Z</i>,5<i>Z</i>)-5-[(Dimethylamino)methylidene]-2-{(<i>E</i>)-[(1<i>R</i>,4<i>R</i>)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-ylidene]hydrazinylidene}thiazolidin-4-one
C16H24N4OS
Acta Crystallographica Section C (2018) 74, 12
a=11.4988(8)Å b=13.5379(11)Å c=22.3107(16)Å
α=90° β=90° γ=90°
(<i>R</i>)-5-[(<i>R</i>)-3-(4-Chlorophenyl)-5-methyl-4,5-dihydroisoxazol-5-yl]-2-methylcyclohex-2-enone
C17H18ClNO2
Acta Crystallographica Section E (2020) 76, 3 400-403
a=6.4590(2)Å b=7.3545(3)Å c=31.3436(12)Å
α=90° β=90° γ=90°
Dimethyl 2-((2<i>Z</i>,5<i>Z</i>)-5-(2-methoxy-2-oxoethylidene)-2-{(<i>E</i>)-[2-methyl-5-(prop-1-en-2-yl)cyclohex-2-enylidene]hydrazinylidene}-4-oxothiazolidin-3-yl)fumarate
C22H25N3O7S
Acta Crystallographica Section E (2017) 73, 2 296-299
a=8.2468(3)Å b=9.8783(4)Å c=15.1039(6)Å
α=96.144(2)° β=105.172(2)° γ=95.750(2)°
(4b<i>S</i>,8a<i>R</i>)-1-Isopropyl-4b,8,8-trimethyl-7-oxo-4b,7,8,8a,9,10-hexahydrophenanthren-2-yl acetate
C22H28O3
Acta Crystallographica Section E (2018) 74, 5 728-730
a=7.4103(2)Å b=10.4681(3)Å c=12.8121(3)Å
α=90° β=102.2350(10)° γ=90°
2-[(3a<i>S</i>,6<i>R</i>)-3,3,6-Trimethyl-3,3a,4,5,6,7-hexahydro-2<i>H</i>-indazol-2-yl]thiazol-4(5<i>H</i>)-one
C13H19N3OS
Acta Crystallographica Section E (2016) 72, 3 334-336
a=8.5519(2)Å b=18.9335(4)Å c=8.9165(3)Å
α=90° β=110.203(3)° γ=90°
(<i>Z</i>)-2-[(<i>Z</i>)-3-Methyl-2-({(<i>E</i>)-1-[(<i>R</i>*)-4-methylcyclohex-3-en-1-yl]ethylidene}hydrazinylidene)-4-oxothiazolidin-5-ylidene]acetate
C16H21N3O3S
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 11 1626-1629
a=9.0982(2)Å b=9.9556(3)Å c=10.5071(3)Å
α=66.7720(10)° β=74.5720(10)° γ=77.7060(10)°
Ethyl 2-[(1,7,7-trimethylbicyclo[2.2.1]hept-2-ylidene)hydrazono]- 2-(4-nitrophenylsulfanyl)acetate
C20H25N3O4S
Acta Crystallographica Section E (2006) 62, 2 o699-o700
a=6.9124(14)Å b=15.398(3)Å c=19.778(4)Å
α=90° β=90° γ=90°
Chloro(η^6^-p-cymene)(2-methyl-5-oxo-7-phenyl-5,6-dihydro-2H-1,2,4-triazepin- 3-thiolato-κ^2^N^4^,S)ruthenium
C21H24ClN3ORuS
Acta Crystallographica Section C (2000) 56, 8 e315-e316
a=20.647(2)Å b=11.8350(10)Å c=17.275(2)Å
α=90.00° β=96.253(5)° γ=90.00°
C11H16Cl2O3
C11H16Cl2O3
Acta Crystallographica Section C (2002) 58, 2 o90-o93
a=7.2419(5)Å b=9.7619(8)Å c=17.7469(16)Å
α=90° β=90° γ=90°
C11H16Br2O3
C11H16Br2O3
Acta Crystallographica Section C (2002) 58, 2 o90-o93
a=7.4006(5)Å b=9.7511(10)Å c=18.0171(13)Å
α=90° β=90° γ=90°